GB Sciences Announces Opening of Las Vegas, Nevada, Indoor Cannabis Grow, Moving GB Sciences into a Revenue Generating Stage

LAS VEGAS, Jan. 4, 2017 /PRNewswire/ -- GB Sciences Nevada, LLC ("GBSN"), a wholly owned subsidiary of GB Sciences, Inc ("GB Sciences" or the "Company"). (OTCQB: GBLX) is pleased to announce the receipt of the State Registration Certificate for its 28,000 sq. ft. cannabis cultivation facility located at 3550 West Teco Avenue in Las Vegas, Clark County, Nevada, which allows the facility to produce cannabis.

"The receipt of the registration certificate is a monumental step for the Company as it will allow us to move forward in a new, cash flow generating, phase. The team and I are extremely excited about the opportunities ahead," said John Poss, GB Sciences' CEO. 

GB Sciences cannabis cultivation facility will initially be equipped with 200 grow lights supporting approximately 800 cannabis plants, with an initial production of 115 pounds of cannabis per month and serve the patient population of Nevada.  When it's at capacity, the facility will have 1,000 grow lights and 4,000 plants, which are expected to generate over $20 million in revenues per year.

About Growblox Sciences, Inc.
GB Sciences, Inc. (GBLX) is a diverse vertically integrated cannabis company, focused on cultivation as well as biopharmaceutical research and development. The Company's goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. To learn more about Growblox Sciences, Inc., go to: http://growblox.com 

Forward-Looking Statements 
This press release may contain statements relating to future results or events, which are forward-looking statements.  Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control.  It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements.  Further, information concerning the Company and its business, including factors that potentially could materially affect the Company's business and financial and other results, are contained in the Company's filings with the Securities and Exchange Commission, available at www.sec.gov.  All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Note:  Although the Company's research and development activities are not illegal, the production and sale of cannabis products violate federal laws as they presently exist.

Contact Information
Corporate:
GB Sciences, Inc., 
3550 West Teco Ave., Las Vegas, NV 89118 
866-721-0297, or  
Liz Bianco Publicity Director, [email protected], http://growblox.com    
Investors: John Poss, [email protected] 

SOURCE GB Sciences, Inc.

Related Links

http://growblox.com